Amanote Research
Register
Sign In
611. Lentiviral Vector Common Integration Sites in the ALD and MLD Clinical Trials and in a Preclinical Model Reflect a Benign Integration Bias and Not Oncogenic Selection
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)37184-2
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2011
Authors
Unknown
Publisher
Elsevier BV
Related search
Host Factors in Retroviral Integration and the Selection of Integration Target Sites
Model Uncertainty, Financial Market Integration and the Home Bias Puzzle
Journal of International Money and Finance
Economics
Econometrics
Finance
316. Integration Site Distribution of Lentiviral Vector in Gene Therapy for X-Adrenoleukodystrophy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
127. Detection of Vector Integration Sites by Targeted Sequencing
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Selection of Target Sites for Mobile DNA Integration in the Human Genome
PLoS Computational Biology
Molecular Neuroscience
Evolution
Ecology
Genetics
Behavior
Molecular Biology
Systematics
Simulation
Cellular
Computational Theory
Mathematics
Modeling
Common Integration Sites for MMTV in Viral Induced Mouse Mammary Tumors
Journal of Mammary Gland Biology and Neoplasia
Cancer Research
Oncology
447. Lentiviral Gene Therapy in a Preclinical Model of Omenn Syndrome
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
636. Mapping of Transposon Integration Sites in Murine and Canine Liver After Transposition From a High-Capacity Adenoviral Vector
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Some Examples in Vector Integration
Bulletin of the Australian Mathematical Society
Mathematics
